Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia

European Respiratory Journal

Volumn 43, Issue 1, 2014, Pages 36-42

  Sibila, Oriol ^a,b   Mortensen, Eric M ^c,d   Anzueto, Antonio ^a,e   Laserna, Elena ^a,f   Restrepo, Marcos I ^a,e,g  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c South Texas Veterans Affairs Health Care System   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^f Hospital Comarcal de Mollet   (Spain)

^g Veterans Evidence Based Research Dissemination and Implementation Center (VERDICT)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; IPRATROPIUM BROMIDE; NICOTINE; THEOPHYLLINE; TIOTROPIUM BROMIDE; VARENICLINE;

AGED; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SURVIVAL TIME; TOBACCO DEPENDENCE; UNSTABLE ANGINA PECTORIS;

AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; MALE; MYOCARDIAL INFARCTION; PNEUMONIA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84891923077     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00117312     Document Type: Review

References (31)

1. Minino AM, Murphy SL, Xu J, et al. Deaths: Final data for 2008. Natl Vital Stat Rep 2011; 59: 1-126.
2. Anzueto A, Sethi S, Martinez FJ. Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4: 554-564.
3. Agust́ A, Barnes PJ. Update in chronic obstructive pulmonary disease 2011. Am J Respir Crit Care Med 2012; 185: 1171-1176.
4. Holguin F, Folch E, Redd SC, et al. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005; 128: 2005-2011.
5. Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16: 63-70.
6. Dewan NA, Rafique S, Kanwar B, et al. Acute exacerbation of COPD: Factors associated with poor treatment outcome. Chest 2000; 117: 662-671.
7. Agabiti N, Belleudi V, Davoli M, et al. Profiling hospital performance to monitor the quality of care: The case of COPD. Eur Respir J 2010; 35: 1031-1038.
8. Restrepo MI, Mortensen EM, Pugh JA, et al. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J 2006; 28: 346-351.
9. Rello J, Rodriguez A, Torres A, et al. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J 2006; 27: 1210-1216.
10. Molinos L, Clemente MG, Miranda B, et al. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. J Infect 2009; 58: 417-424.
11. Menéndez R, Torres A, Zalacán R, et al. Risk factors of treatment failure in community acquired pneumonia: Implications for disease outcome. Thorax 2004; 59: 960-965.
12. Torres A, Dorca J, Zalacán R, et al. Community-acquired pneumonia in chronic obstructive pulmonary disease: A Spanish multicenter study. Am J Respir Crit Care Med 1996; 154: 1456-1461.
13. Liapikou A, Polverino E, Ewig S, et al. Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients. Eur Respir J 2012; 39: 855-861.
14. Mortensen EM, Coley CM, Singer DE, et al. Causes of death for patients with community-acquired pneumonia: Results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 2002; 162: 1059-1064.
15. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245-1251.
16. Perry TW, Pugh MJ, Waterer GW, et al. Incidence of cardiovascular events after hospital admission for pneumonia. Am Med J 2011; 124: 244-251.
17. Sohn MW, Arnold N, Maynard C, et al. Accuracy and completeness of mortality data in the Department of Veterans Affairs. Popul Health Metr 2006; 4: 2.
18. Yende S, Angus DC, Ali IS, et al. Influence of comorbid conditions on long-term mortality after pneumonia in older people. J Am Geriatr Soc 2007; 55: 518-525.
19. Waterer GW, Lessler LA, Wunderink RG. Medium-term survival after hospitalization with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169: 910-914.
20. Macchia A, Monte S, Romero M, et al. The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure. Eur J Heart Fail 2007; 9: 942-948.
21. Sidney S, Sorel M, Quesenberry CP Jr, et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128: 2068-2075.
22. Mortensen EM, Kapoor WN, Chang CC, et al. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis 2003; 37: 1617-1624.
23. Kaplan V, Angus DC, Griffin MF, et al. Hospitalized community-acquired pneumonia in the elderly: Age- and sexrelated patterns of care and outcomes in the United States. Am J Respir Crit Care Med 2002; 165: 766-772.
24. Mortensen EM. Potential causes of increased long-term mortality after pneumonia. Eur Respir J 2011; 37: 1306-1307.
25. Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010; 10: 83-92.
26. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331: 417-424.
27. Kafkas N, Venetsanou K, Patsilinakos S, et al. Procalcitonin in acute myocardial infarction. Acute Card Care 2008; 10: 30-36.
28. Naghavi M, Wyde P, Litovsky S, et al. Influenza infections exerts prominent and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 2003; 107: 762-768.
29. Madjid M, Vela D, Khalili-Tabrizi H, et al. Systemic infections cause exaggerated inflammation in atherosclerotic coronary arteries: Clues to the triggering effect of acute infections on acute coronary syndromes. Tex Heart Inst J 2007; 34: 11-18.
30. Joo MJ, Lee TA, Au DH, et al. Medication use patterns associated with spirometry in diagnosing COPD. COPD 2008; 5: 360-368.
31. Cooke CR, Joo MJ, Anderson SM, et al. The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. BMC Health Serv Res 2011; 11: 37.